Michael A. Greeley, General Partner
Michael is a General Partner at Flybridge Capital Partners focused on information technology, healthcare and medical technology investments. Among a range of general investment themes, Michael is currently focused on opportunities involving the convergence of healthcare and IT, technology-enabled business services, and technologies that address the physical security and homeland defense markets.
Michael currently represents the firm on the boards of BlueTarp Financial, MicroCHIPS, PolyRemedy, Predictive Biosciences, Protein Forest, T2 Biosystems and VidSys and led the firm’s investment in Magen BioSciences.
Michael was named to the 2007 Mass High Tech All-Star List.
Background
Michael founded IDG Ventures Atlantic in 2001 before it transitioned to Flybridge Capital Partners in 2008. Michael served on the board of International Data Group, the flagship Limited Partner for the IDG Ventures global network of funds.
Previously, Michael was with Polaris Venture Partners, where he focused on both early-stage and later-stage financings for emerging growth companies. Before Polaris, Michael served as Senior Vice President and Founding Partner of GCC Investments, a $200 million private equity fund. Prior to GCC Investments, Michael was a Vice President and one of the early professionals at Wasserstein Perella & Co., an international merchant bank with a $1.0 billion private equity fund. Additionally, Michael was a member of the Mergers and Acquisitions Department of Morgan Stanley & Co. and worked in the Leveraged Buyout Group of Credit Suisse First Boston.
In previous positions, Michael has served on the Boards of a number of public and private companies including Global TeleSystems Group (NASDAQ: GTSG), El Sitio International (NASDAQ: LCTO), MotherNature.com (NASDAQ: MTHR), Crescent Communications (acquired by Clear Channel), Fleetcor Technologies and American Capital Access.
Education
Michael received a BA with honors in Chemistry from Williams College and an MBA from Harvard Business School.
Interests
Michael currently serves as the President of the New England Venture Capital Association and serves on the investment committee of the Partners Innovation Healthcare Fund. He is also a member of the Executive Business Advisory Council for Mass General Hospital for Children, and a trustee and on the investment committee of the Massachusetts Eye and Ear Infirmary. Additionally Michael authors a column called “Nothing Ventured” for BioIT World magazine and blogs on the venture industry for Xconomy.
Although Michael considers himself a New Yorker, he grew up in Hong Kong. He is married with two children and is an avid runner, having successfully completed five marathons in the past few years. While at Williams, Michael had a remarkably undistinguished career as a four-year varsity lacrosse player.